Vaxart, Inc. (Nasdaq:VXRT)
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded in 2004 and is headquartered in South San Francisco, CA.
170 Harbor Way
Suite 300
South San Francisco, California 94080
177
$1.1500
1.1500 - 1.2500
0.5300 - 1.5900
1.81M
13.71M (02/29/24)
8.18%
$200.92M
$107K
-$107.76M
N/A
Chairman & Chief Executive Officer Michael J Finney PhD |
Director William Mark Watson CPA |
Lead Independent Director Robert A Yedid MBA |
Independent Director Elaine J Heron PhD, MBA |
Lead Independent Director David E Wheadon MD |
Date | Form | Event |
---|---|---|
17 Dec, 2024 | 4 | |
5 Dec, 2024 | 8-K | |
13 Nov, 2024 | 8-K | |
13 Nov, 2024 | 10-Q | |
8 Oct, 2024 | 424B5 | |
8 Oct, 2024 | 8-K | |
30 Sep, 2024 | 8-K | |
8 Aug, 2024 | 10-Q | |
8 Aug, 2024 | 8-K | |
5 Jul, 2024 | 8-K | |
3 Jul, 2024 | S-8 | |
20 Jun, 2024 | 8-K/A | |
20 Jun, 2024 | 4 | |
18 Jun, 2024 | 8-K | |
17 Jun, 2024 | 424B5 | |
14 Jun, 2024 | 8-K | |
13 Jun, 2024 | 8-K | |
13 Jun, 2024 | 8-K | |
13 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
12 Jun, 2024 | 4 | |
13 May, 2024 | 8-K | |
13 May, 2024 | 10-Q | |
30 Apr, 2024 | 8-K | |
29 Apr, 2024 | ARS | |
29 Apr, 2024 | DEFA14A | |
29 Apr, 2024 | DEF 14A | |
18 Apr, 2024 | PRE 14A | |
1 Apr, 2024 | 4/A | |
1 Apr, 2024 | 4 | |
1 Apr, 2024 | 4 | |
20 Mar, 2024 | 3 | |
20 Mar, 2024 | 4 | |
20 Mar, 2024 | 4 | |
20 Mar, 2024 | 4 | |
20 Mar, 2024 | 4 | |
20 Mar, 2024 | 4 | |
14 Mar, 2024 | 8-K | |
14 Mar, 2024 | S-8 | |
14 Mar, 2024 | 10-K | |
6 Mar, 2024 | 8-K | CEO Change |
29 Feb, 2024 | 8-K | |
15 Feb, 2024 | 8-K | |
13 Feb, 2024 | SC 13G/A | |
2 Feb, 2024 | 8-K/A | |
18 Jan, 2024 | 424B5 | |
16 Jan, 2024 | 8-K | |
16 Jan, 2024 | 8-K | CEO Change |
2 Nov, 2023 | 8-K | |
2 Nov, 2023 | 10-Q | |
23 Oct, 2023 | 8-K | |
23 Oct, 2023 | 8-K/A | |
6 Sep, 2023 | 8-K | |
3 Aug, 2023 | 10-Q | |
3 Aug, 2023 | 8-K | |
1 Aug, 2023 | 4 | |
1 Aug, 2023 | 4 | |
1 Aug, 2023 | 4 | |
1 Aug, 2023 | 4 | |
1 Aug, 2023 | 4 | |
26 Jul, 2023 | 8-K | |
10 Jul, 2023 | 8-K | |
7 Jul, 2023 | SC 13G/A | |
28 Jun, 2023 | 8-K | |
21 Jun, 2023 | DEFA14A | |
14 Jun, 2023 | 4 | |
8 Jun, 2023 | 424B5 | |
8 Jun, 2023 | 8-K | |
6 Jun, 2023 | 424B5 | |
6 Jun, 2023 | 8-K | |
25 May, 2023 | 8-K | |
11 May, 2023 | 4/A | |
9 May, 2023 | 8-K | |
9 May, 2023 | 424B5 | |
5 May, 2023 | EFFECT | |
4 May, 2023 | 10-Q | |
3 May, 2023 | CORRESP | |
28 Apr, 2023 | DEF 14A | |
28 Apr, 2023 | DEFA14A | |
31 Mar, 2023 | 8-K | |
23 Mar, 2023 | UPLOAD | |
21 Mar, 2023 | 4 | |
21 Mar, 2023 | 4 | |
21 Mar, 2023 | 4 | |
21 Mar, 2023 | 4 | |
21 Mar, 2023 | 4 | |
17 Mar, 2023 | S-3 | |
16 Mar, 2023 | 8-K | |
15 Mar, 2023 | 10-K | |
9 Feb, 2023 | SC 13G | |
1 Feb, 2023 | SC 13G/A | |
10 Jan, 2023 | SC 13G/A | |
30 Dec, 2022 | 3 | |
30 Dec, 2022 | 4 | |
28 Dec, 2022 | 4 | |
19 Dec, 2022 | 8-K | |
6 Dec, 2022 | 8-K | |
9 Nov, 2022 | 10-Q | |
8 Nov, 2022 | 8-K | |
24 Oct, 2022 | S-8 | |
7 Oct, 2022 | 4 | |
1 Sep, 2022 | 8-K | |
26 Aug, 2022 | 4 | |
25 Aug, 2022 | 8-K | |
25 Aug, 2022 | 4 | |
25 Aug, 2022 | 3 | |
22 Aug, 2022 | 4 | |
8 Aug, 2022 | 4 | |
8 Aug, 2022 | 4 | |
8 Aug, 2022 | 4 | |
8 Aug, 2022 | 4 | |
8 Aug, 2022 | 4 | |
8 Aug, 2022 | 8-K | |
8 Aug, 2022 | 10-Q | |
8 Aug, 2022 | 3 | |
8 Aug, 2022 | 4 | |
5 Aug, 2022 | 8-K/A | |
28 Jul, 2022 | 8-K | |
26 Jul, 2022 | DEFA14A | |
26 Jul, 2022 | DEFA14A | |
12 Jul, 2022 | DEFA14A | |
8 Jul, 2022 | 8-K | |
6 Jul, 2022 | 8-K | |
1 Jul, 2022 | DEFA14A | |
1 Jul, 2022 | DEFA14A | |
28 Jun, 2022 | 8-K | |
24 Jun, 2022 | DEFA14A | |
23 Jun, 2022 | 4 | |
16 Jun, 2022 | 8-K | |
8 Jun, 2022 | 8-K | |
6 Jun, 2022 | 8-K | |
25 May, 2022 | DEFA14A | |
18 May, 2022 | DEFA14A | |
12 May, 2022 | 3 | |
11 May, 2022 | 8-K | |
10 May, 2022 | 8-K | |
9 May, 2022 | 10-Q | |
28 Apr, 2022 | DEF 14A | |
28 Apr, 2022 | DEFA14A | |
25 Apr, 2022 | 4 | |
18 Apr, 2022 | PRE 14A | |
31 Mar, 2022 | 8-K | |
30 Mar, 2022 | 4 | |
30 Mar, 2022 | 4 | |
30 Mar, 2022 | 4 | |
10 Mar, 2022 | SC 13G/A | |
24 Feb, 2022 | 10-K | |
24 Feb, 2022 | 8-K | |
22 Feb, 2022 | 4 | |
22 Feb, 2022 | 3 | |
15 Feb, 2022 | 8-K | |
11 Feb, 2022 | SC 13G/A | |
7 Feb, 2022 | SC 13G | |
23 Dec, 2021 | 4 | |
1 Dec, 2021 | 8-K | |
1 Dec, 2021 | 4 | |
4 Nov, 2021 | 10-Q | |
4 Nov, 2021 | 8-K | |
13 Oct, 2021 | 4 | |
7 Oct, 2021 | 3 | |
21 Sep, 2021 | 8-K | |
16 Sep, 2021 | 8-K/A | |
16 Sep, 2021 | 424B5 | |
16 Sep, 2021 | 424B5 | |
16 Sep, 2021 | 8-K | |
13 Sep, 2021 | 4 | |
23 Aug, 2021 | 4 | |
23 Aug, 2021 | 3 | |
23 Aug, 2021 | 8-K | |
11 Aug, 2021 | 4 | |
11 Aug, 2021 | 4 | |
5 Aug, 2021 | 8-K | |
5 Aug, 2021 | 10-Q | |
2 Aug, 2021 | 8-K | |
21 Jul, 2021 | 4 | |
20 Jul, 2021 | 8-K | |
9 Jul, 2021 | 8-K | |
21 Jun, 2021 | S-8 | |
21 Jun, 2021 | 4 | |
21 Jun, 2021 | 8-K | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
14 Jun, 2021 | 4/A | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4/A | |
11 Jun, 2021 | 4 | |
10 May, 2021 | 4 | |
6 May, 2021 | 10-Q | |
3 May, 2021 | 8-K | |
30 Apr, 2021 | DEFA14A | |
30 Apr, 2021 | DEF 14A | |
23 Apr, 2021 | 8-K | |
23 Apr, 2021 | 3 | |
13 Apr, 2021 | 8-K | |
18 Mar, 2021 | 4 | |
5 Mar, 2021 | 4 | |
25 Feb, 2021 | 10-K | |
25 Feb, 2021 | 8-K | |
11 Feb, 2021 | SC 13G | |
3 Feb, 2021 | 8-K | |
3 Feb, 2021 | 8-K | |
29 Jan, 2021 | 8-K | |
29 Jan, 2021 | UPLOAD | |
27 Jan, 2021 | CORRESP | |
22 Jan, 2021 | UPLOAD | |
8 Jan, 2021 | CORRESP | |
28 Dec, 2020 | UPLOAD |
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.